SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Latchana David A

(Last)

(First)

(Middle)

C/O 9341 COURTLAND DRIVE NE

(Street)

ROCKFORD

49351

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2024

3. Issuer Name and Ticker or Trading Symbol
WOLVERINE WORLD WIDE INC /DE/ [ WWW ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	13,889	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to Buy)⁽¹⁾	02/11/2016	02/10/2025	Common Stock	4,007	$28	D
Stock Options (Right to Buy)⁽²⁾	02/10/2017	02/09/2026	Common Stock	7,706	$16.51	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock	711	$0⁽⁴⁾	D
Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Common Stock	1,200	$0⁽⁴⁾	D
Restricted Stock Units	⁽⁶⁾	⁽⁶⁾	Common Stock	2,389	$0⁽⁴⁾	D
Restricted Stock Units	⁽⁷⁾	⁽⁷⁾	Common Stock	4,182	$0⁽⁴⁾	D
Restricted Stock Units	⁽⁸⁾	⁽⁸⁾	Common Stock	7,912	$0⁽⁴⁾	D
Restricted Stock Units	⁽⁹⁾	⁽⁹⁾	Common Stock	7,829	$0⁽⁴⁾	D

Explanation of Responses:

1. This option became exercisable as to 1,336 shares on February 11, 2016, as to 1,335 shares on February 11, 2017, and as to 1,336 shares on February 11, 2018.

2. This option became exercisable as to 2,569 shares on February 10, 2017, as to 2,568 shares on February 10, 2018, and as to 2,569 shares on February 10, 2019.

3. On February 9, 2021, the Reporting Person was granted 2,368 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: 20%, 20%, 30% and 30% on each of the first, second, third and fourth year anniversaries of the grant date, respectively. The restricted stock units have no expiration date.

4. Restricted stock units convert into shares of Common Stock on a one-for-one basis.

5. On February 9, 2022, the Reporting Person was granted 1,999 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: 20%, 20%, 30% and 30% on each of the first, second, third and fourth year anniversaries of the grant date, respectively. The restricted stock units have no expiration date.

6. On February 8, 2023, the Reporting Person was granted 3,584 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: one-third on each of the first, second, and third year anniversaries of the grant date. The restricted stock units have no expiration date.

7. On November 22, 2023, the Reporting Person was granted 4,182 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: 100% on the first anniversary of the grant date. The restricted stock units have no expiration date.

8. On February 7, 2024, the Reporting Person was granted 7,912 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: one-third on each of the first, second, and third year anniversaries of the grant date. The restricted stock units have no expiration date.

9. On April 29, 2024, the Reporting Person was granted 7,829 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: one-third on each of the first, second, and third year anniversaries of the grant date. The restricted stock units have no expiration date.

Remarks:

	/s/ David Latchana	05/10/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.